Lukast Chewable Tablet 4 mg (Montelukast Sodium)

Adult dose

The medication should be taken once daily; for asthma patients, it is recommended to take it in the evening, while for allergic rhinitis patients, the timing should be determined based on the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet once daily in the evening. This medication should be administered one hour before a meal or two hours after a meal.

Child dose

Children aged 2-5 years: Chew 4 mg once daily as montelukast. This medication should be administered one hour before a meal or two hours after a meal.

This medication is used to treat asthma and allergic rhinitis. During treatment, psychiatric side effects may occur; hence, patients and caregivers should monitor for changes such as anxiety, aggressive behavior, depression, hallucinations, and suicidal thoughts. If any of these symptoms occur, discontinue use immediately and consult a physician. This medication contains aspartame, an artificial sweetener, so patients with phenylketonuria should avoid using it. Lactose is included, thus patients with galactose intolerance, lactose deficiency, or glucose-galactose malabsorption should also refrain from using this medication. This medication is not an emergency treatment for acute asthma attacks and a fast-acting inhaled bronchodilator should be used for acute symptoms. It is advisable to avoid taking aspirin or non-steroidal anti-inflammatory drugs during treatment, especially for patients with aspirin sensitivity. While prolonged use does not significantly increase adverse reactions, symptoms such as fever, headache, abdominal pain, cough, and rash may occur. Consult a physician before use if pregnant or breastfeeding; caution is also needed for children and the elderly. There are no specific antidotes for overdose, so general treatment should be followed based on symptoms and under the direction of a physician. This medication should be kept out of reach of children and should not be transferred to another container for safety. If asthma symptoms worsen or new symptoms appear during usage, consult a physician and do not unilaterally stop or adjust the dosage.

Serious side effects

Urticaria, angioedema, toxic epidermal necrolysis, Stevens-Johnson syndrome, anaphylaxis (severe allergic reaction), vasculitic rash, exacerbation of pulmonary symptoms, cardiac complications and neuropathies, suicidal thoughts and behaviors (including suicide), cognitive confusion, seizures, seizure disorder, serious psychiatric adverse events, severe edema

Mild side effects

Anxiety, aggressive behavior, mood disorders, depression, disorientation, attention deficit, stuttering, sleep disorders and hallucinations, insomnia, memory impairment, obsessive-compulsive disorder, hyperactivity (including irritability, instability, and restlessness), sleepwalking, tics, dizziness, drowsiness, sensory disturbances/hypoesthesia, seizure disorder, palpitations, epistaxis, lung eosinophilia, diarrhea, dyspepsia, nausea, vomiting, increased ALT and AST levels, thrombocytopenia, itching, rash, blood

This medication is sensitive to moisture and light, so it should be stored at room temperature between 1°C to 30°C. It is also important to keep it in a tightly sealed container to prevent air exposure.

Appearance

Pink, oval-shaped chewable tablet with a biconvex surface on both sides

Package unit

28 tablets/Alu-Alu (7 tablets/Alu-Alu pack × 4 EA)